Background: The independent role of mild autonomous cortisol secretion (ACS) in influencing the cardiovascular event (CVE) occurrence is a topic of interest. We investigated the role of mild ACS in the CVE occurrence in patients with adrenal incidentaloma (AI) by standard statistics and artificial neural networks (ANNs).

Methods: We analyzed a retrospective record of 518 AI patients. Data regarding cortisol levels after 1 mg dexamethasone suppression (1 mg DST) and the presence of obesity (OB), hypertension (AH), type-2 diabetes (T2DM), dyslipidemia (DL), familial CVE history, smoking habit and CVE were collected.

Results: The receiver-operating characteristic curve analysis suggested that 1 mg DST, at a cut-off of 1.8 µg/dL, had the best accuracy for detecting patients with increased CVE risk. In patients with 1 mg-DST ≥1.8 µg/dL (DST+,  = 223), age and prevalence of AH, T2DM, DL and CVE (66 years, 74.5, 25.9, 41.4 and 26.8% respectively) were higher than that of patients with 1 mg-DST ≤1.8 µg/dL (61.9 years, 60.7, 18.5, 32.9 and 10%, respectively,  < 0.05 for all). The CVE were associated with DST+ (OR: 2.46, 95% CI: 1.5-4.1,  = 0.01), regardless of T2DM, AH, DL, smoking habit, gender, observation period and age. The presence of at least two among AH, T2DM, DL and OB plus DST+ had 61.1% sensitivity in detecting patients with CVE. By using the variables selected by ANNs (familial CVE history, age, T2DM, AH, DL and DST+) 78.7% sensitivity was reached.

Conclusions: Cortisol after 1 mg-DST is independently associated with the CVE occurrence. The ANNs might help for assessing the CVE risk in AI patients.

Download full-text PDF

Source
http://dx.doi.org/10.1530/EJE-17-0047DOI Listing

Publication Analysis

Top Keywords

mild autonomous
8
autonomous cortisol
8
cortisol secretion
8
artificial neural
8
neural networks
8
role mild
8
cve occurrence
8
patients 1 mg-dst
8
patients
6
cve
6

Similar Publications

The functionalization of the C-N bond of amines is a straightforward strategy for the construction of complex scaffolds or for the late-stage functionalization of pharmaceuticals. Herein, we describe a photoredox-catalyzed strategy for the deaminative alkylation of primary amine-derived isonitriles that provides unnatural amino acid derivatives under mild conditions. The use of silacarboxylic acids as silyl radical precursors enables the generation of carbon-centered radicals that allow the construction of Csp-Csp bonds via a Giese-type addition, avoiding the undesired hydrodeamination product.

View Article and Find Full Text PDF

Background: Acute variceal bleeding (AVB), a life-threatening complication of liver cirrhosis, can be effectively treated by endoscopy, but there is a risk of early rebleeding after endoscopic variceal treatment (EVT). Thrombocytopenia is the most common hemostatic abnormality in liver cirrhosis. However, it is still unclear about whether thrombocytopenia increases the failure of EVT in cirrhotic patients with AVB.

View Article and Find Full Text PDF

Newly synthesized 1-bromo-2-(4-bromophenylsulfonate)-4,4-dimethyl-1-cyclohexenyl-6-one (CHD) as a potential anticorrosive agent in an acidic medium at an elevated temperature range of 305-335 K. This synthesized compound confirmed by spectral characterizations and it acts as a coating on mild steel surfaces in 1 M Hydrochloric acid (HCl) solution through electrochemical reactions. The synthesis of the compound has been discussed, and the Infrared (IR) and Nucleic Magnetic Resonance (NMR) spectral analysis confirmed the derivative.

View Article and Find Full Text PDF

Objective: Patients with mild autonomous cortisol secretion (MACS) are at increased risk of cardiometabolic outcomes, such as hyperglycemia, metabolic syndrome, and cardiovascular diseases. Nonalcoholic fatty liver disease (NAFLD) is also associated with increased cardiometabolic risk. We aimed to investigate the prevalence and predictors of NAFLD in metabolically healthy subjects with MACS.

View Article and Find Full Text PDF
Article Synopsis
  • Patients with rheumatic diseases tend to recover from COVID-19 faster (average 13 days) compared to their family members (average 16 days), despite being on immunosuppressive treatments.
  • The study found that rheumatic patients have a lower risk of developing moderate to severe COVID-19, with pre-infection use of NSAIDs linked to a higher chance of mild cases.
  • Patients using disease-modifying anti-rheumatic drugs (DMARDs) before infection were significantly less likely to develop severe cases compared to those who were not on these medications.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!